Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Share Price

Equities

300018

CNE100000GP0

Electrical Components & Equipment

End-of-day quote Shenzhen S.E. 23:00:00 25/04/2024 BST 5-day change 1st Jan Change
4.89 CNY -2.78% Intraday chart for Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. +0.62% -19.97%

Financials

Sales 2022 443M 61.11M 4.89B Sales 2023 448M 61.84M 4.95B Capitalization 2.94B 405M 32.47B
Net income 2022 8M 1.1M 88.42M Net income 2023 60M 8.28M 663M EV / Sales 2022 5.23 x
Net cash position 2022 606M 83.63M 6.7B Net cash position 2023 678M 93.5M 7.49B EV / Sales 2023 5.04 x
P/E ratio 2022
304 x
P/E ratio 2023
47 x
Employees 732
Yield 2022
0.82%
Yield 2023
0.82%
Free-Float 67.74%
More Fundamentals * Assessed data
Dynamic Chart
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Wuhan Zhongyuan Huadian Chairman Resigns; Vice Chairman Succeeds MT
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. cancelled the transaction announced on April 26, 2020 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Biaodi Electronics announced that it has received $1.5 million in funding from Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. CI
Rui Shuangyin agreed to acquire 35.56% stake in Anhui Daqian Bio-Engineering Limited Company from Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. for CNY 12.2 million. CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
More news
1 day-2.78%
1 week+0.62%
Current month-8.94%
1 month-5.05%
3 months-9.94%
6 months-17.82%
Current year-19.97%
More quotes
1 week
4.66
Extreme 4.66
5.10
1 month
4.46
Extreme 4.46
5.63
Current year
3.43
Extreme 3.43
6.26
1 year
3.43
Extreme 3.43
7.18
3 years
3.43
Extreme 3.43
9.18
5 years
3.43
Extreme 3.43
10.85
10 years
3.26
Extreme 3.26
34.50
More quotes
Managers TitleAgeSince
Founder 65 15/11/01
Director of Finance/CFO 53 19/10/11
Chairman 63 31/10/01
Members of the board TitleAgeSince
President 51 31/10/01
Chairman 57 31/10/01
Founder 65 15/11/01
More insiders
Date Price Change Volume
26/04/24 4.89 -2.78% 13,614,400
25/04/24 5.03 +0.20% 7,460,000
24/04/24 5.02 +4.80% 8,529,018
23/04/24 4.79 +0.21% 7,455,755
22/04/24 4.78 -1.65% 6,101,800

End-of-day quote Shenzhen S.E., April 25, 2024

More quotes
WUHAN ZHONGYUAN HUADIAN SCIENCE & TECHNOLOGY CO., LTD. is a China-based company principally engaged in the research, development, manufacture and sales of electrical power system intelligent record analysis products, time synchronization products, transformer substation integrated automation systems and automated distribution equipment, as well as the provision of related services for its products. The Company operates through two main segments. The Transmission and Distribution and Control Equipment Manufacturing segment is mainly engaged in the research, development, manufacture and sales of power failure recording devices, time synchronization devices, substation integrated automation system and distribution automation equipment. The Medical Health segment is engaged in the research, development and manufacture of medical information products and in-vitro diagnostic equipment.
Calendar
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300018 Stock